CXCL12, CXCR4 and CXCR7 Expression in brain metastases

Andrea Salmaggi, Emanuela Maderna, Chiara Calatozzolo, Paola Gaviani, Alessandra Canazza, Ida Milanesi, Silvani Antonio, Francesco DiMeco, Antonino Carbone, Bianca Pollo

Research output: Contribution to journalArticle

Abstract

Brain metastases occur in about 25% of patients who die of cancer. The most common sources of brain metastases in adults are lung, breast, kidney, colorectal cancer and melanoma. The chemokine/receptor system CXCL12/CXCR4 plays a key role in multiple biological functions; among these, homing of neoplastic cells from the primary site to the target and metastasis progression. Recently, an alternative CXCL12 receptor CXCR7 has been discovered. The aim of our study was to investigate the expression of CXCL12 and its receptors CXCR4 and CXCR7 by immunohistochemistry in 56 patients with metastatic brain disease from different non-CNS primary tumors, and evaluate their prognostic relevance as well as that of other patient/treatment-related features on patient survival. CXCL12 showed an expression in tumor cells and in tumor vessels; CXCR7 was expressed by tumor and endothelial cells (both within the tumor and in the adjacent brain tissue), while CXCR4 showed a positivity in all samples with a nuclear pattern. Among the investigated immunohistochemical parameters, only CXCL12 expression in tumor endothelial cells showed a statistically significant correlation with shorter survival (p = 0.04 log-rank), perhaps identifying more aggressive tumors. Thus, this is the first study evaluating at the same time the expression of CXCL12 and its two receptors in a cohort of brain metastases.

Original languageEnglish (US)
Pages (from-to)1608-1614
Number of pages7
JournalCancer Biology and Therapy
Volume8
Issue number17
DOIs
StatePublished - Sep 1 2009
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Brain
Neoplasms
Endothelial Cells
CXCR4 Receptors
Survival
Kidney Neoplasms
Chemokine Receptors
Brain Diseases
Colorectal Neoplasms
Melanoma
Breast
Immunohistochemistry
Lung

Keywords

  • Brain metastasis
  • Chemokine
  • Clinical correlation
  • CXCL12
  • CXCR4
  • CXCR7
  • Immunohistochemistry

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Molecular Medicine
  • Pharmacology

Cite this

Salmaggi, A., Maderna, E., Calatozzolo, C., Gaviani, P., Canazza, A., Milanesi, I., ... Pollo, B. (2009). CXCL12, CXCR4 and CXCR7 Expression in brain metastases. Cancer Biology and Therapy, 8(17), 1608-1614. https://doi.org/10.4161/cbt.8.17.9202

CXCL12, CXCR4 and CXCR7 Expression in brain metastases. / Salmaggi, Andrea; Maderna, Emanuela; Calatozzolo, Chiara; Gaviani, Paola; Canazza, Alessandra; Milanesi, Ida; Antonio, Silvani; DiMeco, Francesco; Carbone, Antonino; Pollo, Bianca.

In: Cancer Biology and Therapy, Vol. 8, No. 17, 01.09.2009, p. 1608-1614.

Research output: Contribution to journalArticle

Salmaggi, A, Maderna, E, Calatozzolo, C, Gaviani, P, Canazza, A, Milanesi, I, Antonio, S, DiMeco, F, Carbone, A & Pollo, B 2009, 'CXCL12, CXCR4 and CXCR7 Expression in brain metastases', Cancer Biology and Therapy, vol. 8, no. 17, pp. 1608-1614. https://doi.org/10.4161/cbt.8.17.9202
Salmaggi A, Maderna E, Calatozzolo C, Gaviani P, Canazza A, Milanesi I et al. CXCL12, CXCR4 and CXCR7 Expression in brain metastases. Cancer Biology and Therapy. 2009 Sep 1;8(17):1608-1614. https://doi.org/10.4161/cbt.8.17.9202
Salmaggi, Andrea ; Maderna, Emanuela ; Calatozzolo, Chiara ; Gaviani, Paola ; Canazza, Alessandra ; Milanesi, Ida ; Antonio, Silvani ; DiMeco, Francesco ; Carbone, Antonino ; Pollo, Bianca. / CXCL12, CXCR4 and CXCR7 Expression in brain metastases. In: Cancer Biology and Therapy. 2009 ; Vol. 8, No. 17. pp. 1608-1614.
@article{a85873fa963844e08f7399f9a58d155f,
title = "CXCL12, CXCR4 and CXCR7 Expression in brain metastases",
abstract = "Brain metastases occur in about 25{\%} of patients who die of cancer. The most common sources of brain metastases in adults are lung, breast, kidney, colorectal cancer and melanoma. The chemokine/receptor system CXCL12/CXCR4 plays a key role in multiple biological functions; among these, homing of neoplastic cells from the primary site to the target and metastasis progression. Recently, an alternative CXCL12 receptor CXCR7 has been discovered. The aim of our study was to investigate the expression of CXCL12 and its receptors CXCR4 and CXCR7 by immunohistochemistry in 56 patients with metastatic brain disease from different non-CNS primary tumors, and evaluate their prognostic relevance as well as that of other patient/treatment-related features on patient survival. CXCL12 showed an expression in tumor cells and in tumor vessels; CXCR7 was expressed by tumor and endothelial cells (both within the tumor and in the adjacent brain tissue), while CXCR4 showed a positivity in all samples with a nuclear pattern. Among the investigated immunohistochemical parameters, only CXCL12 expression in tumor endothelial cells showed a statistically significant correlation with shorter survival (p = 0.04 log-rank), perhaps identifying more aggressive tumors. Thus, this is the first study evaluating at the same time the expression of CXCL12 and its two receptors in a cohort of brain metastases.",
keywords = "Brain metastasis, Chemokine, Clinical correlation, CXCL12, CXCR4, CXCR7, Immunohistochemistry",
author = "Andrea Salmaggi and Emanuela Maderna and Chiara Calatozzolo and Paola Gaviani and Alessandra Canazza and Ida Milanesi and Silvani Antonio and Francesco DiMeco and Antonino Carbone and Bianca Pollo",
year = "2009",
month = "9",
day = "1",
doi = "10.4161/cbt.8.17.9202",
language = "English (US)",
volume = "8",
pages = "1608--1614",
journal = "Cancer Biology and Therapy",
issn = "1538-4047",
publisher = "Landes Bioscience",
number = "17",

}

TY - JOUR

T1 - CXCL12, CXCR4 and CXCR7 Expression in brain metastases

AU - Salmaggi, Andrea

AU - Maderna, Emanuela

AU - Calatozzolo, Chiara

AU - Gaviani, Paola

AU - Canazza, Alessandra

AU - Milanesi, Ida

AU - Antonio, Silvani

AU - DiMeco, Francesco

AU - Carbone, Antonino

AU - Pollo, Bianca

PY - 2009/9/1

Y1 - 2009/9/1

N2 - Brain metastases occur in about 25% of patients who die of cancer. The most common sources of brain metastases in adults are lung, breast, kidney, colorectal cancer and melanoma. The chemokine/receptor system CXCL12/CXCR4 plays a key role in multiple biological functions; among these, homing of neoplastic cells from the primary site to the target and metastasis progression. Recently, an alternative CXCL12 receptor CXCR7 has been discovered. The aim of our study was to investigate the expression of CXCL12 and its receptors CXCR4 and CXCR7 by immunohistochemistry in 56 patients with metastatic brain disease from different non-CNS primary tumors, and evaluate their prognostic relevance as well as that of other patient/treatment-related features on patient survival. CXCL12 showed an expression in tumor cells and in tumor vessels; CXCR7 was expressed by tumor and endothelial cells (both within the tumor and in the adjacent brain tissue), while CXCR4 showed a positivity in all samples with a nuclear pattern. Among the investigated immunohistochemical parameters, only CXCL12 expression in tumor endothelial cells showed a statistically significant correlation with shorter survival (p = 0.04 log-rank), perhaps identifying more aggressive tumors. Thus, this is the first study evaluating at the same time the expression of CXCL12 and its two receptors in a cohort of brain metastases.

AB - Brain metastases occur in about 25% of patients who die of cancer. The most common sources of brain metastases in adults are lung, breast, kidney, colorectal cancer and melanoma. The chemokine/receptor system CXCL12/CXCR4 plays a key role in multiple biological functions; among these, homing of neoplastic cells from the primary site to the target and metastasis progression. Recently, an alternative CXCL12 receptor CXCR7 has been discovered. The aim of our study was to investigate the expression of CXCL12 and its receptors CXCR4 and CXCR7 by immunohistochemistry in 56 patients with metastatic brain disease from different non-CNS primary tumors, and evaluate their prognostic relevance as well as that of other patient/treatment-related features on patient survival. CXCL12 showed an expression in tumor cells and in tumor vessels; CXCR7 was expressed by tumor and endothelial cells (both within the tumor and in the adjacent brain tissue), while CXCR4 showed a positivity in all samples with a nuclear pattern. Among the investigated immunohistochemical parameters, only CXCL12 expression in tumor endothelial cells showed a statistically significant correlation with shorter survival (p = 0.04 log-rank), perhaps identifying more aggressive tumors. Thus, this is the first study evaluating at the same time the expression of CXCL12 and its two receptors in a cohort of brain metastases.

KW - Brain metastasis

KW - Chemokine

KW - Clinical correlation

KW - CXCL12

KW - CXCR4

KW - CXCR7

KW - Immunohistochemistry

UR - http://www.scopus.com/inward/record.url?scp=70350317612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350317612&partnerID=8YFLogxK

U2 - 10.4161/cbt.8.17.9202

DO - 10.4161/cbt.8.17.9202

M3 - Article

C2 - 19625779

AN - SCOPUS:70350317612

VL - 8

SP - 1608

EP - 1614

JO - Cancer Biology and Therapy

JF - Cancer Biology and Therapy

SN - 1538-4047

IS - 17

ER -